A recent study using HCT116 and SW620 CRC cell lines demonstrated that ANXA1 exhibits both diagnostic and prognostic biomarker potential, while also emphasizing its variable expression in different cellular models [68]. The gene discussed is ANXA1; the disease is colorectal carcinoma.